These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8732118)

  • 1. [Prognostic factors affecting the results of surgical treatment of cervical cancer].
    Lou H; Chen Y; Sun H
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):64-6. PubMed ID: 8732118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
    Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
    J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of five hundred and thirty patients with early stage I and II stage cervical carcinoma.
    Wang R
    Chin Med J (Engl); 1997 Apr; 110(4):255-8. PubMed ID: 9594223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
    Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
    Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy.
    Kodama J; Seki N; Masahiro S; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
    J Surg Oncol; 2010 Apr; 101(5):413-7. PubMed ID: 20127891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
    Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
    Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
    Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
    Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma.
    Piver MS; Chung WS
    Obstet Gynecol; 1975 Nov; 46(5):507-10. PubMed ID: 1196552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
    Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.